TY - JOUR
T1 - Gait Dysfunction in Motoric Cognitive Risk Syndrome
AU - Ayers, Emmeline
AU - Verghese, Joe
N1 - Funding Information:
This study was supported by funds from the National Institute on Aging (R56AG057548). The Central Control of Mobility in Aging is supported by National Institute on Aging grants (R01AG04 4007-01A1: J Verghese and R01AG036921-01A1: R Holtzer).
Publisher Copyright:
© 2019-IOS Press and the authors. All rights reserved.
PY - 2019
Y1 - 2019
N2 - Background: Motoric cognitive risk (MCR) syndrome is a cognitive-motor syndrome associated with increased risk of transition to dementia. The clinical phenotype of MCR is not yet established. Objective: To systematically assess clinical gait abnormalities in older adults with MCR. Methods: Of the 522 community-dwelling non-demented adults aged 65 and older enrolled in the Central Control of Mobility in Aging study, 43 were diagnosed with MCR (47% women) based on presence of cognitive complaints and slow gait velocity (MCRv). Four additional subtypes of MCR were defined by substituting slow gait with short stride length (MCRsl, n=41), slow swing time (MCRsw, n=21), high stride length variability (MCRslv, n=24), and high swing time variability (MCRswv, n=25). The prevalence of clinical gait abnormalities (neurological or non-neurological) in MCR overall (n=81) and subtypes was studied. We also examined if gait abnormalities predicted further cognitive and functional decline in MCR cases. Results: Most clinical gait abnormalities were mild (walked without assistance) in the five MCR subtypes (44 to 61%). Neurological (range 24 to 46%) and non-neurological gait abnormalities (33 to 61%) were common in all MCR subtypes. Neurological gaits were most frequent in MCRsl (46%) and non-neurological gaits in MCRv (61%). Over a median 3.02 years of follow-up, presence of gait abnormality in MCR cases at baseline predicted worsening disability scores (estimate 0.17, p-value=0.033) but not decline on cognitive scores (p-value=0.056). Conclusion: Clinical gait abnormalities are common in MCR syndrome and its subtypes, and are associated with accelerated functional decline.
AB - Background: Motoric cognitive risk (MCR) syndrome is a cognitive-motor syndrome associated with increased risk of transition to dementia. The clinical phenotype of MCR is not yet established. Objective: To systematically assess clinical gait abnormalities in older adults with MCR. Methods: Of the 522 community-dwelling non-demented adults aged 65 and older enrolled in the Central Control of Mobility in Aging study, 43 were diagnosed with MCR (47% women) based on presence of cognitive complaints and slow gait velocity (MCRv). Four additional subtypes of MCR were defined by substituting slow gait with short stride length (MCRsl, n=41), slow swing time (MCRsw, n=21), high stride length variability (MCRslv, n=24), and high swing time variability (MCRswv, n=25). The prevalence of clinical gait abnormalities (neurological or non-neurological) in MCR overall (n=81) and subtypes was studied. We also examined if gait abnormalities predicted further cognitive and functional decline in MCR cases. Results: Most clinical gait abnormalities were mild (walked without assistance) in the five MCR subtypes (44 to 61%). Neurological (range 24 to 46%) and non-neurological gait abnormalities (33 to 61%) were common in all MCR subtypes. Neurological gaits were most frequent in MCRsl (46%) and non-neurological gaits in MCRv (61%). Over a median 3.02 years of follow-up, presence of gait abnormality in MCR cases at baseline predicted worsening disability scores (estimate 0.17, p-value=0.033) but not decline on cognitive scores (p-value=0.056). Conclusion: Clinical gait abnormalities are common in MCR syndrome and its subtypes, and are associated with accelerated functional decline.
KW - Cognition
KW - gait
KW - motoric cognitive risk syndrome
UR - http://www.scopus.com/inward/record.url?scp=85072586847&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85072586847&partnerID=8YFLogxK
U2 - 10.3233/JAD-181227
DO - 10.3233/JAD-181227
M3 - Article
C2 - 30909242
AN - SCOPUS:85072586847
SN - 1387-2877
VL - 71
SP - S95-S103
JO - Journal of Alzheimer's Disease
JF - Journal of Alzheimer's Disease
IS - s1
ER -